Biologic & Small Molecule NP/PA CME Virtual Bootcamp

Join Us For 7 Hours of Free CME/CE Credit!

Saturday, October 17, 2020

 

Learning Objectives

  • Describe recent advances in biologic drug development, regulations, and indications in immune-mediated inflammatory diseases (IMIDs), with emphasis on psoriasis, PsA and AD.
  • Critically appraise and discuss relevant evidence on pathophysiology and immunology as applied to psoriasis, psoriatic arthritis and atopic dermatitis.
  • Develop strategies to predict, prevent, and treat potential side effects and complications encountered with biologic agents.
  • Review data regarding associated comorbid conditions associated with psoriasis, PsA, and AD including but not limited to cardiovascular disease, diabetes, obesity, and depression.
  • Analyze recent investigations on safety, efficacy, and toxicity of biologic agents across IMIDs.
  • Through case-based presentation and discussion panels, summarize updates in diagnosis, classification, therapies, and immune-system targets in psoriasis, PsA, and AD and describe their clinical implications.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education, LLC, the Dermatology Education Foundation, and Physician Resources, LLC. Evolve Medical Education, LLC is accredited by the ACCME to provide continuing medical education for physicians.

PA Continuing Education
PAs may claim a maximum of 7 Category 1 credits for completing this activity. National Commission on Certification of Physician Assistants (NCCPA) accepts AMA PRA Category 1 Credits(TM) from organizations accredited by ACCME or a recognized state medical society.

Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits(TM)  from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

Evolve Medical Education, LLC designates this live activity for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Surveys will be utilized and collated pre-meeting, onsite, and post-meeting. During the registration process and prior to the Bootcamp, a survey will be conducted. Audience response system monitoring will be conducted onsite and follow-up electronic surveys will be conducted post-meeting to assess the learning objectives and other key measurements.

Faculty Disclosures

  • April Armstrong has had a financial agreement or affiliation during the past year with the following commercial interests in the form of: Consultant: Abbvie, Bristol-Myers Squibb, Dermavant, Eli Lilly, Janssen, LEO Pharma, Modernizing Medicine, Novartis AG, Ortho Dermatologics, Pfizer, Inc ., Regeneron Pharmaceuticals, Sanofi Genzyme and Science 37. Grant/Research Support: Abbvie, Bristol-Myers Squibb, Dermira, Eli Lilly, Janssen, Kyowa Hakko Kirin, LEO Pharma, Novartis, Regeneron, Sanofi, and UCB

  • David Cohen, MD, MPH, FAAD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of: Consultant: Cutanea, Dermavant, Ferndale Laboratories, Ferrer, FIDE and Medimetriks. Stock Shareholder: Brickell Biotech, Kadmon, Dermira, Inc., and Medimetriks.

  • Kara Gooding, MMS, PA-C, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Janssen, Novartis Pharmaceuticals, Sun Pharma, and UCB. Speaker’s Bureau: Aclaris Therapeutics, Almirall, Celgene, Dermira, LEO Pharma, and Pfizer.

  • Joseph Gorelick, MSN, FNP-C has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: AbbVie Pharmaceuticals, Dermira, Lilly, LEO Pharma, Novartis Pharmaceuticals, Ortho Dermatologics, Pfizer, PruGen, Regeneron Pharmaceuticals, Sanofi Genzyme, Sun Pharma, and UCB. Advisory Board/Speaker’s Bureau: AbbVie Pharmaceuticals, Dermira, Lilly, LEO Pharma; Novartis Pharmaceuticals, Ortho Dermatologics, Pfizer, PruGen, Regeneron Pharmaceuticals, Sun Pharma, and UCB.

  • Accreditation and Medical Education Support Disclosure
    • Susan Gallagher-Pecha and Erin Fletcher of Evolve Medical Education LLC have no real or apparent conflicts of interest to report.
    • Stacey Moore of Physician Resources, LLC has no real or apparent conflicts of interest to report.

    Supported by an educational grant from LEO Pharma.

    CME Certificate Instructions

    You will have access to the recorded content in the app until November 5, 2020.

    You will have until October 17, 2021 to complete the post-test evaluation to earn your certificate.

    Upon completion of the 7.0 hours of the CME activities, please complete your post-test evaluations by registering/signing into the website of our CME accreditor, Evolve Medical Education. Please note that this account is separate from your Whova account for the Bootcamp app access.

    Visit this link to log in or sign in and complete the post-test evaluations:

    https://evolvemeded.com/course-group/def-biologic-small-molecule-np-pa-cme-bootcamp-virtual-in-person/

    Any questions or concerns about CME, please contact Erin Fletcher at Evolve Medical Education at [email protected]